Oral methylene blue and the dissolution of renal calculi.
Oral methylene blue therapy was not effective in dissolving non-obstructive renal calculi in 26 patients but it may prevent new stone formation in patients with metabolically active urolithiasis. The use of methylene blue therapy in combination with other regimens having different mechanisms of stone inhibition is recommended to further improve results.
D000284:Administration, Oral; D000328:Adult; D002136:Calcium, Dietary / Q000008:administration & dosage; D002648:Child; D005260:Female; D006801:Humans; D007669:Kidney Calculi / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008751:Methylene Blue / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D014552:Urinary Tract Infections / Q000150:complications
D002136:Calcium, Dietary; D008751:Methylene Blue